Get the app
US › Healthcare

Voyager Therapeutics Inc (VYGR)

US · Healthcare · Biotechnology

$1.90-7.77%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$3.2M
Revenue YoY
-39.1%
Net profit
$-24.5M
EPS
$-0.40
EPS estimate
$-0.55
Net margin
-773.2%

EPS came in at -0.40 against a street estimate of -0.55 — a beat of 27.3%.

Key statistics

Market cap
$126.9M
Forward P/E
8.4
P/B
1.15
Book value
$2.52
EPS (TTM)
$-1.81
52-week high
$5.48
52-week low
$1.89
50-day MA
$3.01
200-day MA
$3.58
Beta
1.28

Analyst view

Analysts rate Voyager Therapeutics Inc a strong buy (11 buy, 0 hold, 0 sell out of 11) with an average price target of $14.89.

Shareholding

Insiders
14.84%
Institutions
57.87%

Largest institutional holders

FundStake
BlackRock Inc8.39%
Millennium Management LLC7.21%
Armistice Capital, LLC5.58%
Vestal Point Capital LP4.26%
Vanguard Capital Management, LLC3.81%
Geode Capital Management, LLC2.16%
Opaleye Management Inc1.92%
State Street Corp1.75%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Voyager Therapeutics Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.